Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
425 Leser
Artikel bewerten:
(2)

Sigma Labs, Inc.: Sigma Labs Reports Second Quarter 2021 Financial Results

Management to Host Conference Call Today at 4:30 p.m. ET

SANTA FE, NM / ACCESSWIRE / July 22, 2021 / Sigma Labs, Inc. (NASDAQ:SGLB) ("Sigma Labs"), a leading developer of quality assurance software for the commercial 3D metal printing industry, has reported its financial and operational results for the second quarter ended June 30, 2021.

Key Second Quarter Highlights

Announced several key developments, including:

  • Released PrintRite3D Version 7.0, an industry-leading system for in-process quality assurance for industrial 3D manufacturers, with breakthroughs in quality and economics driven by temperature calibration. Developed after extensive input from existing customers, 3D metal printing manufacturers, universities and standards organizations, the next generation PrintRite3D 7.0 contains upgrades to existing features, as well as significant new functionality that meets industry demands driving enhanced quality and better economics for end-users.
  • Recognized at the American Society of Mechanical Engineers' AM Tech Forum as the winner of the Best-in-Class Innovation Award for Additive Manufacturing Measurement and Analysis, chosen based on multiple criteria including impact on speed, cost, and quality; range of potential use across applications and industries; level of innovation-from an improvement to a game changer; and how likely they would purchase.
  • Added to the Russell Microcap Index enabling greater access and visibility to institutional investors and investment managers.

Management Commentary

"Despite the ongoing unpredictability and delays in the market due to the international effects of the pandemic, users in current and new markets in aerospace, space exploration and defense are showing strong interest, engagement and activity level with us," said Mark K. Ruport, President and CEO of Sigma Labs. "We also continue to see validation from our clients and from our prospective clients who are testing our solution, and from industry associations with our Best-in-Class Innovation Award from the American Society of Mechanical Engineers. We believe our solutions remain a crucial ingredient to help accelerate the adoption of additive manufacturing and increase the success of the 3D metal printing industry.

"During the quarter we released PrintRite3D version 7.0, with key features such as Temperature Monitoring and Calibration, including a cooling rate metric and units/traceability for TEP ("Thermal Emission Planck") to Celsius/Kelvin conversion, and Neural Net Machine Learning Recoater Interaction Detection that allows users to automatically spot recoater interaction detection with higher diagnostic accuracy. Taken together, we believe the unique benefits of the update provide a competitive advantage for our customers and believe positions us to help accelerate the growth of the additive manufacturing industry.

"Looking ahead, our team remains confident in our technology and strategy, industry growth, and our ability to capture market share with our first mover advantage, significant barriers to entry, and leveraged business model. The Industry outlook is positive, however, given the stage of the industry, timing of our contracts can have an impact on any particular quarter, especially with the delays resulting from Covid-19 in the reopening of Europe and Asia.

"With our recently strengthened balance sheet, we now have over $14.7 million in cash to support growth, direct sales and marketing. For the second half of the year, we are focusing on seeking to expand sales through our partnerships with DMG MORI and Additive Industries, and increased direct sales to global end-user manufacturers, universities and R&D organizations. We also continue to seek new and expanded strategic partnerships with 3D printer OEMs, software companies, and integrators. We look forward to sharing additional updates as the year progresses," concluded Ruport.

Second Quarter 2021 Financial Results

Revenue for the second quarter of 2021 totaled $144,148. This compares to revenues of $167,688 for the second quarter of 2020. The decrease in revenue was primarily due a decrease of $29,864 in revenue from our Rapid Test and Evaluation program from the second quarter of 2020.

Gross profit for the second quarter of 2021 was $27,751 as compared to $110,004 in the second quarter of 2020.

Total operating expenses for the second quarter of 2021 were $2.2 million as compared to total operating expenses of $1.5 million for the same period in 2020. The increase was mainly attributable additional employee headcount, R&D expenses and organizational costs.

Cash used in operating activities for the six months ended June 30, 2021, totaled $3.3 million compared to $2.4 million in the second quarter of 2020, an increase of $0.8 million.

Net loss for the second quarter of 2021 was $1.9 million, or $(0.18) per share, as compared to a net loss of $1.6 million, or $(0.49) per share, in the second quarter of 2020.

Cash totaled $14.7 million at June 30, 2021, as compared to $3.7 million at December 31, 2020. The increase in cash during the period was a result of a $5.1 million public offering of common stock and a follow-on $9.7 million registered direct offering of common stock and short-term warrants. In addition, warrant exercises during the first quarter of 2021 have contributed an additional $1.1 million in cash proceeds.

Second Quarter 2021 Results Conference Call

Sigma Labs President and CEO Mark Ruport and CFO Frank Orzechowski will host the conference call, followed by a question-and-answer period.

To access the call, please use the following information:

Date:Thursday, July 22, 2021
Time:4:30 p.m. Eastern time, 1:30 p.m. Pacific time
Toll-free dial-in number:1-877-407-9039
International dial-in number:1-201-689-8470
Conference ID:13721685

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact MZ Group at 1-949-491-8235.

The conference call will be broadcast live and available for replay at http://public.viavid.com/index.php?id=145807 and via the investor relations section of the Company's website at www.sigmalabsinc.com.

A replay of the conference call will be available after 7:30 p.m. Eastern time through August 5, 2021.

Toll-free replay number:

1-844-512-2921

International replay number:

1-412-317-6671

Replay ID:

13721685

About Sigma Labs

Sigma Labs Inc. is a leading provider of in-process quality assurance (IPQA®) software to the additive manufacturing industry. Sigma Labs specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D® for 3D metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process, enabling significant cost-savings and production efficiencies. Sigma Labs believes its software product will be a major catalyst for the acceleration and adoption of 3D metal printing. For more information, please visit www.sigmalabsinc.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are risks relating to, among other things, market and other conditions, Sigma Labs' business and financial condition, the extent of the market's acceptance of PrintRite3D version 7.0, Sigma Labs' ability to satisfy its capital needs through increasing its revenue and obtaining additional financing, and the impact of COVID-19, general economic, industry or political conditions in the United States or internationally. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see disclosures contained in Sigma Labs' public filings with the SEC, including the "Risk Factors" in Sigma Labs' Annual Report on Form 10-K, and which may be viewed at www.sec.gov.

Contacts:

Investor Contact:

Chris Tyson
Executive Vice President
MZ Group - MZ North America
949-491-8235
SGLB@mzgroup.us
www.mzgroup.us

Company Contact:

Steven Gersten
Sigma Internal IR
813-334-9745
investors@sigmalabsinc.com

Sigma Labs, Inc.
Condensed Balance Sheets
(Unaudited)

June 30, 2021 December 31, 2020
ASSETS
Current Assets:
Cash
$14,731,115 $3,700,814
Accounts Receivable, net
389,450 331,562
Inventory
846,999 659,651
Prepaid Assets
168,326 90,735
Total Current Assets
16,135,890 4,782,762
Other Assets:
Property and Equipment, net
157,490 138,626
Intangible Assets, net
793,465 753,122
Long-Term Prepaid Asset
- 26,000
Total Other Assets
950,955 917,748
TOTAL ASSETS
$17,086,845 $5,700,510
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts Payable
$315,768 $128,937
Deferred Revenue
63,569 77,957
Accrued Expenses
184,099 243,815
Total Current Liabilities
563,436 450,709
Long-Term Liabilities:
Stock Appreciation Rights
93,525 48,341
CARES Act Deferred Payroll Tax Liability
37,728 37,728
Total Long-Term Liabilities
131,253 86,069
TOTAL LIABILITIES
694,689 536,778
Stockholders' Equity
Preferred Stock, $0.001 par; 10,000,000 shares authorized; 465 and 715 issued and outstanding, respectively
1 1
Common Stock, $0.001 par; 24,000,000 shares authorized; 10,493,598 and 5,995,320 issued and outstanding, respectively
10,494 5,995
Additional Paid-In Capital
52,058,003 38,262,744
Accumulated Deficit
(35,676,342) (33,105,008)
Total Stockholders' Equity
16,392,156 5,163,732
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
$17,086,845 $5,700,510

See accompanying notes to condensed financial statements.

Sigma Labs, Inc.
Condensed Statements of Operations
(Unaudited)

Three Months Ended
June 30,
Six Months Ended
June 30,
2021 2020 2021 2020
REVENUES
$144,148 $167,688 $602,288 $389,418
COST OF REVENUE
116,397 57,684 244,728 302,387
GROSS PROFIT (LOSS)
27,751 110,004 357,560 87,031
OPERATING EXPENSES:
Salaries & Benefits
985,348 605,295 1,832,520 1,257,492
Stock-Based Compensation
116,441 270,818 233,919 424,989
Operating R&D Costs
280,700 111,647 477,040 165,335
Investor & Public Relations
114,762 97,702 223,103 287,009
Organization Costs
158,529 80,096 236,145 155,675
Legal & Professional Service Fees
244,019 212,496 420,866 397,386
Office Expenses
151,871 78,843 300,096 226,590
Depreciation & Amortization
25,783 17,970 48,814 35,983
Other Operating Expenses
91,198 51,687 177,554 135,736
Total Operating Expenses
2,168,651 1,526,554 3,950,057 3,086,195
LOSS FROM OPERATIONS
(2,140,900) (1,416,550) (3,592,497) (2,999,164)
OTHER INCOME (EXPENSE)
Interest Income
7,018 31 7,073 882
State Incentives
- 151,657 - 151,657
Exchange Rate Gain (Loss)
208 (31) 158 (1,422)
Interest Expense
(2,029) (6,244) (3,382) (6,675)
Loss on Dissolution of Joint Venture
- (201) - (201)
Other Income
290,156 361,700 1,092,441 361,700
Total Other Income (Expense)
295,353 506,912 1,096,290 505,941
LOSS BEFORE PROVISION FOR INCOME TAXES
(1,845,547) (909,638) (2,496,207) (2,493,223)
Provision for income Taxes
- - - -
Net Loss
$(1,845,547) $(909,638) $(2,496,207) $(2,493,223)
Preferred Dividends
(14,220) (691,880) (75,127) (1,007,127)
Net Loss Applicable to Common Stockholders
$(1,859,767) $(1,601,518) $(2,571,334) $(3,500,350)
Net Loss per Common Share - Basic and Diluted
$(0.18) $(0.49) $(0.28) $(1.48)
Weighted Average Number of Shares Outstanding - Basic and Diluted
10,493,598 3,256,098 9,149,328 2,359,862

Sigma Labs, Inc.
Condensed Statements of Cash Flows
(Unaudited)

Six Months Ended
June 30, 2021 June 30, 2020
OPERATING ACTIVITIES
Net Loss
$ (2,496,207) $ (2,493,223)
Adjustments to reconcile Net Loss to Net Cash used in operating activities:
Noncash Expenses:
Depreciation and Amortization
48,814 35,983
Gain on Derivative Liability
(1,092,441) -
Stock Based Compensation - Employees
233,919 424,989
Stock Based Compensation - Third Party Services
55,937 54,924
Stock Based Compensation - Directors
122,274 -
Change in assets and liabilities:
Accounts Receivable
(57,888) (230,865)
Inventory
(187,348) 13,078
Prepaid Assets
(51,591) 81,695
Accounts Payable
186,831 (431,893)
Deferred Revenue
(14,388) (39,860)
Accrued Expenses
(14,531) 149,785
NET CASH USED IN OPERATING ACTIVITIES
(3,266,620) (2,435,387)
INVESTING ACTIVITIES
Purchase of Property and Equipment
(52,931) (11,474)
Purchase of Intangible Assets
(55,090) (87,736)
Dissolution of Joint Venture
- 500
NET CASH USED IN INVESTING ACTIVITIES
(108,021) (98,710)
FINANCING ACTIVITIES
Gross Proceeds from Public and Private Issuances of Securities
14,869,899 3,600,000
Less Offering Costs
(1,600,967) (820,228)
Payment of Note Payable
- (50,000)
Proceeds from Exercise of Warrants
1,136,010 2,141,100
Deferral of Payroll Taxes under the CARES Act
- 22,072
NET CASH PROVIDED BY FINANCING ACTIVITIES
14,404,942 4,892,944
NET CHANGE IN CASH FOR PERIOD
11,030,301 2,358,847
CASH AT BEGINNING OF PERIOD
3,700,814 86,919
CASH AT END OF PERIOD
$ 14,731,115 $ 2,445,766
Supplemental Disclosures:
Noncash investing and financing activities disclosure:
Issuance of Common Shares for Preferred Dividends
$ 75,108 $ 1,006,717
Issuance of Securities for services
$ 178,209 $ 62,794
Disclosure of cash paid for:
Interest
$ 3,382 $ 9,359
Income Taxes
$ - $ -

SOURCE: Sigma Labs, Inc.



View source version on accesswire.com:
https://www.accesswire.com/656686/Sigma-Labs-Reports-Second-Quarter-2021-Financial-Results

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2021 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.